Welcome to Lyophilization and Freeze Drying Summit 2016.
Today, a number of pharmaceutical and biotech manufacturers are increasingly expanding their existing lyophilization capacities in order to enhance the lifespan of the high value products such as vaccines, antibodies, proteins, enzymes, hormones, blood plasma, and bacteria-derived compounds. In addition, there is an increasing adoption of technologically advanced lyophilization solutions in the pharmaceutical industry to minimize human intervention in the lyophilization process to avoid contamination risks for the high value pharmaceutical and biotech products. However, shortage of skilled personnel with the expertise to operate, maintain, and scale up lyophilization systems, expensive set up and maintenance costs of lyophilization systems, rising adoption of refurbished freeze drying systems by pharmaceutical companies for cost-cutting activities, emergence and increasing utilization of alternative drying techniques in the pharmaceutical and biotechnology industry, may restrain the growth of this market during the forecast period of 2014 to 2019.
In 2013, Asia-Pacific region held nearly 1/3rd of the global market share, followed by North America with a share of ~30%. The highest market share of Asia-Pacific region is attributed to the presence and expansion of major pharmaceutical and biotechnology companies in these regions, especially in China, India, and Japan. Shift of pharmaceutical companies to this low cost manufacturing region as well as focus of expansion of major market players are the major growth drivers for the lyophilization equipment in Asia-Pacific region.
Here is where we can help! YBS Global Lyophilization and freeze drying summit has brought together industry thought leaders to walk you through the tedious process of lypholization and freeze drying. This event will provide invaluable insight into what is coming next in 2016 and beyond. Gain an in-depth perspective on the ever-changing international regulations, major growth drivers and explore the cutting-edge FDA pilot programs in our dynamic workshops. Take advantage of the opportunity to hear new innovated programs put in place by top companies in our unique case studies and walk away with a deep understanding of key industry trends and solutions.
Come the Discussion with Thought Leaders from a Range of Expertise, Including
- Advances, developments and Emerging Technologies in Freeze Drying
- How to apply QBD and PAT to the lyophilization process.
- Practical Methodologies, challenges in cycle development.
- Design Space Development for Lyophilization (DOE)- Tech Transfer.
- Freezing step in the lyophilisation cycle development & its impact on the product
- Freeze drying of proteins, biologics and Generics / Protein Stability:
- Design of energy Saving and Intelligent Drug Production Lyophilizer
- Lyophilization – Development Through Tech Transfer.
- Current challenges in Lyophilization – A packaging perspective.
- Process optimization and Troubleshoot.
From startup and mid-size pharma to multi-national giants, we’ll address the challenges that are unique to manufacturers, distributors, dispensers, CMOs and CPOs according to varying sizes and resources. But we’ll also be tackling the tough questions that are common to all, such as
Explore the development of formulations for more complex biologics.
Explore Best Practices from industry experts Expand your professional Network
Latest updates, challenges and importance of implementing lyophilisation process and its relevance to Pharma and Bio Industry.
Best Practices from industry experts Expand your professional Network
Evaluate the latest tools Innovative Services from cutting edge Vendors.
About the Venue
Novotel Hotel, The city has already emerged as a pharmaceutical hub of India. Its bio-pharmaceuticals exports reached US$5.2 billion in 2014–2015. Due to abundance of pharma companies, it is also known as “Genome Valley of India” and India’s pharmaceutical capital. It supports its economy and ultimately backs India. As per industrial growth policy, the Telangana government has declared pharma and IT as the top two priority sectors. To expand these industries in better ways, the government has planned to provide hassle-free environment.